213 related articles for article (PubMed ID: 16758744)
61. Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease.
Gärtner BC; Schäfer H; Marggraff K; Eisele G; Schäfer M; Dilloo D; Roemer K; Laws HJ; Sester M; Sester U; Einsele H; Mueller-Lantzsch N
J Clin Microbiol; 2002 Feb; 40(2):351-8. PubMed ID: 11825941
[TBL] [Abstract][Full Text] [Related]
62. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
63. Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation.
Peric Z; Cahu X; Chevallier P; Brissot E; Malard F; Guillaume T; Delaunay J; Ayari S; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Saulquin B; Harousseau JL; Moreau P; Milpied N; Coste-Burel M; Imbert-Marcille BM; Mohty M
Leukemia; 2011 Jun; 25(6):932-8. PubMed ID: 21350556
[TBL] [Abstract][Full Text] [Related]
64. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
Sundin M; Le Blanc K; Ringdén O; Barkholt L; Omazic B; Lergin C; Levitsky V; Remberger M
Haematologica; 2006 Aug; 91(8):1059-67. PubMed ID: 16885046
[TBL] [Abstract][Full Text] [Related]
65. Epstein-barr virus-related gastric adenocarcinoma: an early secondary cancer post hemopoietic stem cell transplantation.
Au WY; Pang A; Chan EC; Chu KM; Shek TW; Kwong YL
Gastroenterology; 2005 Dec; 129(6):2058-63. PubMed ID: 16344071
[TBL] [Abstract][Full Text] [Related]
66. Epstein-Barr virus DNA load kinetics analysis in allogeneic hematopoietic stem cell transplant recipients: Is it of any clinical usefulness?
Solano C; Mateo EM; Pérez A; Talaya A; Terol MJ; Albert E; Giménez E; Vinuesa V; Piñana JL; Boluda JCH; Navarro D
J Clin Virol; 2017 Dec; 97():26-32. PubMed ID: 29096390
[TBL] [Abstract][Full Text] [Related]
67. Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation.
Engelmann I; Welte T; Fühner T; Simon AR; Mattner F; Hoy L; Schulz TF; Gottlieb J
J Clin Virol; 2009 May; 45(1):47-53. PubMed ID: 19303808
[TBL] [Abstract][Full Text] [Related]
68. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
Meijer E; Cornelissen JJ
Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928
[TBL] [Abstract][Full Text] [Related]
69. Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection.
Ahya VN; Douglas LP; Andreadis C; Arnoldi S; Svoboda J; Kotloff RM; Hadjiliadis D; Sager JS; Woo YJ; Pochettino A; Schuster SJ; Stadtmauer EA; Tsai DE
J Heart Lung Transplant; 2007 Aug; 26(8):839-44. PubMed ID: 17692789
[TBL] [Abstract][Full Text] [Related]
70. Time course and frequency of Epstein-Barr virus reactivation after kidney transplantation: linkage to renal allograft rejection.
Jabs WJ; Maurmann S; Wagner HJ; Müller-Steinhardt M; Steinhoff J; Fricke L
J Infect Dis; 2004 Nov; 190(9):1600-4. PubMed ID: 15478064
[TBL] [Abstract][Full Text] [Related]
71. T-cell posttransplant lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.
Kuno M; Ito A; Maeshima AM; Taniguchi H; Tanaka T; Inamoto Y; Kurosawa S; Kim SW; Fukuda T
Int J Hematol; 2020 Aug; 112(2):193-199. PubMed ID: 32472530
[TBL] [Abstract][Full Text] [Related]
72. Epstein-Barr viral load measurement as a marker of EBV-related disease.
Fan H; Gulley ML
Mol Diagn; 2001 Dec; 6(4):279-89. PubMed ID: 11774193
[TBL] [Abstract][Full Text] [Related]
73. Monitoring of EBV-DNAemia by quantitative real-time PCR after adult liver transplantation.
Loginov R; Aalto S; Piiparinen H; Halme L; Arola J; Hedman K; Höckerstedt K; Lautenschlager I
J Clin Virol; 2006 Oct; 37(2):104-8. PubMed ID: 16931140
[TBL] [Abstract][Full Text] [Related]
74. Immunohistochemical analysis and Epstein-Barr virus in the tonsils of transplant recipients and healthy controls.
Mowry SE; Strocker AM; Chan J; Takehana C; Kalantar N; Bhuta S; Shapiro NL
Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):936-9. PubMed ID: 18794437
[TBL] [Abstract][Full Text] [Related]
75. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
Wu JF; Ho MC; Ni YH; Chen HL; Lu CY; Hsu HY; Lee PH; Chang MH
Transplantation; 2009 Mar; 87(5):758-62. PubMed ID: 19295323
[TBL] [Abstract][Full Text] [Related]
76. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME
J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591
[TBL] [Abstract][Full Text] [Related]
77. [Significance of Epstein-Barr virus DNA quantitation in donors of hematopoietic stem cell transplantation].
Jung S; Lim J; Cho BS; Chae H; Kim M; Kim Y; Han K; Lee JW; Min WS
Korean J Lab Med; 2010 Dec; 30(6):554-8. PubMed ID: 21157138
[TBL] [Abstract][Full Text] [Related]
78. Quantification of Epstein-Barr virus-DNA load in lung transplant recipients: a comparison of plasma versus whole blood.
Bakker NA; Verschuuren EA; Veeger NJ; van der Bij W; van Imhoff GW; Kallenberg CG; Hepkema BG
J Heart Lung Transplant; 2008 Jan; 27(1):7-10. PubMed ID: 18187080
[TBL] [Abstract][Full Text] [Related]
79. Comparison of a LightCycler-based real-time PCR for quantitation of Epstein-Barr viral load in different clinical specimens with semiquantitative PCR.
Krumbholz A; Meerbach A; Zell R; Gruhn B; Henke A; Birch-Hirschfeld E; Wutzler P
J Med Virol; 2006 May; 78(5):598-607. PubMed ID: 16555269
[TBL] [Abstract][Full Text] [Related]
80. Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection.
Hara S; Hoshino Y; Naitou T; Nagano K; Iwai M; Suzuki K; Yamamoto K; Nagasaka T; Morishima T; Kimura H
J Clin Virol; 2006 Mar; 35(3):250-6. PubMed ID: 16181807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
